Argentina-Alzheimer's Disease Neuroimaging Initiative (Arg-ADNI)
The Arg-ADNI was established to advance Alzheimer's research in Latin America. Its primary aim is to validate and develop biomarkers for Alzheimer's disease, facilitating early detection, tracking, and understanding of the disease. This study is part of the World Wide Alzheimer's Disease Neuroimaging Initiative (WW-ADNI), an umbrella organisation for similar neuroimaging initiatives. At baseline, 56 participants were recruited at the Institute for Neurological Research at Fleni and underwent a baseline assessment in 2012 and follow-ups at 12, 30, and 60 months.
Study design
Cohort
Number of participants at first data collection
56 (participants)
Age at first data collection
55 - 85 years (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
No
Sample features
Country
Year of first data collection
2012
Primary Institutions
Alzheimer's Association
Foundation for the Fight against Neurological Diseases in Childhood (Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia, Fleni)
Links
alz.org/research/for_researchers/partnerships/wwadni/argentina_adni
Profile paper DOI
Funders
Foundation for the Fight against Neurological Diseases in Childhood (Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia, Fleni)
Ongoing?
No
Data types collected
- Computer, paper or task testing (e.g. cognitive testing, theory of mind doll task, attention computer tasks)
- Interview – face-to-face
- Physical or biological assessment (e.g. blood, saliva, gait, grip strength, anthropometry)
- None
- Magnetic Resonance Imaging (MRI)
- Positron Emission Tomography (PET)
- None
Engagement
Keywords
Consortia and dataset groups
